<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="iso-abbrev">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="publisher-id">An Bras Dermatol</journal-id>
      <journal-title-group>
        <journal-title>Anais Brasileiros de Dermatologia</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0365-0596</issn>
      <issn pub-type="epub">1806-4841</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Dermatologia</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">24346883</article-id>
      <article-id pub-id-type="pmc">3876004</article-id>
      <article-id pub-id-type="doi">10.1590/abd1806-4841.20132154</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Linear IgA bullous dermatosis: report of an exuberant case<xref ref-type="fn" rid="fn01">*</xref>
</article-title>
        <trans-title-group xml:lang="pt">
          <trans-title>Dermatose por IgA Linear: relato de um caso exuberante</trans-title>
        </trans-title-group>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>de Souza</surname>
            <given-names>Beatriz Cavalcanti</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
          <xref ref-type="corresp" rid="c01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Fregonesi</surname>
            <given-names>N&#xE1;dire Cristina Freire Pontes</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Tebcherani</surname>
            <given-names>Ant&#xF4;nio Jos&#xE9;</given-names>
          </name>
          <xref ref-type="aff" rid="aff02">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sanchez</surname>
            <given-names>Ana Paula Galli</given-names>
          </name>
          <xref ref-type="aff" rid="aff03">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Aoki</surname>
            <given-names>Val&#xE9;ria</given-names>
          </name>
          <xref ref-type="aff" rid="aff04">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Fernandes</surname>
            <given-names>Juliana Christien</given-names>
          </name>
          <xref ref-type="aff" rid="aff05">5</xref>
        </contrib>
      </contrib-group>
      <aff id="aff01"><label>1</label> Medical degree - Resident Physician, Dermatology Service, Complexo
Hospitalar Padre Bento de Guarulhos - Guarulhos (SP), Brazil.</aff>
      <aff id="aff02"><label>2</label> PhD in Science, University of Sao Paulo (Universidade de Sao Paulo -
USP) - Head of the Laboratory of Dermatopathology, Dermatology Service, Hospital
Padre Bento de Guarulhos - Guarulhos (SP), Brazil.</aff>
      <aff id="aff03"><label>3</label> MSc in Science, School of Medicine, University of Sao Paulo (USP)
- Attending physician, Dermatology Service, Complexo Hospitalar Padre Bento
de Guarulhos - Guarulhos (SP), Brazil.</aff>
      <aff id="aff04"><label>4</label> Professor of Dermatology, School of Medicine, University of Sao Paulo
(USP) - Associate Professor, Department of Dermatology, School of Medicine, University
of Sao Paulo (USP) - Sao Paulo (SP), Brazil.</aff>
      <aff id="aff05"><label>5</label> Dermatologist - Preceptor of the Dermatology Service, Complexo
Hospitalar Padre Bento de Guarulhos - Guarulhos (SP), Brazil.</aff>
      <author-notes>
        <corresp id="c01"><bold>Mailing address:</bold> Beatriz Cavalcanti de Souza, Rua Bela Cintra, n 336,
apto 34 - Consola&#xE7;&#xE3;o, CEP 01415-000 - S&#xE3;o Paulo - SP, Brazil. E-mail:
<email>biamedunesp@hotmail.com</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <season>Nov-Dec</season>
        <year>2013</year>
      </pub-date>
      <volume>88</volume>
      <issue>6 Suppl 1</issue>
      <fpage>67</fpage>
      <lpage>70</lpage>
      <history>
        <date date-type="received">
          <day>23</day>
          <month>9</month>
          <year>2012</year>
        </date>
        <date date-type="accepted">
          <day>23</day>
          <month>10</month>
          <year>2012</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9;2013 by Anais Brasileiros de Dermatologia</copyright-statement>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative
Commons Attribution Non-Commercial License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the
original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Linear immunoglobulin A dermatosis is a rare autoimmune bullous disease, but the most
common autoimmune bullous dermatosis in children. We report a typical exuberant case
of linear IgA dermatosis in a ten-month old child, who showed good response to
treatment with corticosteroids and dapsone.</p>
      </abstract>
      <trans-abstract xml:lang="pt">
        <p>A dermatose por imunoglobulina A (IgA) linear &#xE9; doen&#xE7;a bolhosa autoimune rara, por&#xE9;m
a mais comum das dermatoses bolhosas autoimunes da inf&#xE2;ncia. Relatamos caso t&#xED;pico e
exuberante de dermatose por IgA linear em uma crian&#xE7;a de 10 meses, que apresentou boa
evolu&#xE7;&#xE3;o com o tratamento com cortic&#xF3;ide e dapsona.</p>
      </trans-abstract>
      <kwd-group>
        <kwd>Basement membrane</kwd>
        <kwd>Immunoglobulin A</kwd>
        <kwd>Skin diseases, vesiculobullous</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>INTRODUCTION</title>
      <p>Linear immunoglobulin A (IgA) dermatosis is an autoimmune bullous disease characterized
by subepidermal blister formation and the linear and homogenous deposition of IgA at the
basement membrane zone (BMZ).<sup><xref ref-type="bibr" rid="r01">1</xref></sup> In
linear IgA dermatosis (LAD), autoantibodies recognize multiple BMZ antigens, which are
responsible for the different clinical aspects of the disease.<sup><xref ref-type="bibr" rid="r02">2</xref></sup> Although it is a rare dermatosis, it is the most common
autoimmune bullous dermatosis in children.<sup><xref ref-type="bibr" rid="r03">3</xref></sup> It is essential that dermatologists know about it, for a delay in its
diagnosis can lead to secondary infection of the lesions and, less frequently, produce
morbidities such as ocular scarring and pharyngolaryngeal stenosis.<sup><xref ref-type="bibr" rid="r04">4</xref></sup>
</p>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p>We report the case of a ten-month old white male patient from Guarulhos presenting with
isolated and grouped tense serum-filled vesicles and bullae on healthy skin or on an
erythematous base, mostly in a rosette pattern (<xref ref-type="fig" rid="f01">Figures
1</xref> and <xref ref-type="fig" rid="f02">2</xref>). The patient did not present
mucosal lesions or fever, and there was no impairment of the patient's general
condition. There was intense pruritus. His complete blood count was normal. We raised a
suspicion of linear IgA dermatosis and of erythema multiforme. An anatomopathological
examination of a bullous lesion showed subepidermal cleavage with neutrophilic
inflammatory infiltrate (<xref ref-type="fig" rid="f03">Figures 3</xref> and <xref ref-type="fig" rid="f04">4</xref>). Direct immunofluorescence (DIF) of perilesional
skin showed intense linear deposition of IgA at the BMZ (<xref ref-type="fig" rid="f05">Figure 5</xref>). As we awaited the results of the anatomopathological examination,
DIF, and of the glucose-6-phosphate dehydrogenase test, we initiated treatment with
prednisolone 1mg/kg and observed partial improvement of the patient's condition. After
confirming the diagnosis of linear IgA dermatosis and detecting normal levels of glucose
6-phosphate dehydrogenase, we added dapsone 2mg/kg and maintained the oral
corticosteroid therapy, with the patient achieving complete remission (<xref ref-type="fig" rid="f06">Figure 6</xref>). </p>
      <fig id="f01" orientation="portrait" position="float">
        <label>FIGURE 1</label>
        <caption>
          <p>Disseminated bulluous lesions</p>
        </caption>
        <graphic xlink:href="abd-88-06-s1-0067-g01"/>
      </fig>
      <fig id="f02" orientation="portrait" position="float">
        <label>FIGURE 2</label>
        <caption>
          <p>Typical lesions in a rosette pattern</p>
        </caption>
        <graphic xlink:href="abd-88-06-s1-0067-g02"/>
      </fig>
      <fig id="f03" orientation="portrait" position="float">
        <label>FIGURE 3</label>
        <caption>
          <p>HE-200x. Subepidermal cleft showing intact roof and neutrophilic inflammatory
infiltrate with fibrin deposition on the floor</p>
        </caption>
        <graphic xlink:href="abd-88-06-s1-0067-g03"/>
      </fig>
      <fig id="f04" orientation="portrait" position="float">
        <label>FIGURE 4</label>
        <caption>
          <p>HE 200x. Focal subepidermal cleavage associated with intense neutrophilic
infiltrate (circle)</p>
        </caption>
        <graphic xlink:href="abd-88-06-s1-0067-g04"/>
      </fig>
      <fig id="f05" orientation="portrait" position="float">
        <label>FIGURE 5</label>
        <caption>
          <p>Linear deposition of IgA at the basement membrane</p>
        </caption>
        <graphic xlink:href="abd-88-06-s1-0067-g05"/>
      </fig>
      <fig id="f06" orientation="portrait" position="float">
        <label>FIGURE 6</label>
        <caption>
          <p>Clinical improvement after treatment with prednisolone and dapsone</p>
        </caption>
        <graphic xlink:href="abd-88-06-s1-0067-g06"/>
      </fig>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>The first reports on LAD date from 1901-1905, when it was still considered a
manifestation of dermatitis herpetiformis (DH). It was only 80 years later that it was
differentiated from other bullous dermatoses of childhood.<sup><xref ref-type="bibr" rid="r04">4</xref></sup>
</p>
      <p>LAD can affect children as well as adults. In children, it usually begins after the age
of six months, with a peak incidence at 4 to 5 years. It rarely persists after puberty.
In adults, it usually commences after puberty or after the age of 60.<sup><xref ref-type="bibr" rid="r04">4</xref></sup> It affects all races, with a slight
predominance in females.<sup><xref ref-type="bibr" rid="r01">1</xref>,<xref ref-type="bibr" rid="r05">5</xref>,<xref ref-type="bibr" rid="r06">6</xref></sup>
</p>
      <p>According to the age group affected, two different clinical patterns are
found.<sup><xref ref-type="bibr" rid="r05">5</xref></sup> The childhood form is
characterized by tense annular or arcuate bullae and vesicles with serous or hemorrhagic
fluid. The emergence of new bullae at the periphery of previous lesions confers their
classic rosette-like aspect.<sup><xref ref-type="bibr" rid="r06">6</xref></sup> They are
mainly located on the lower abdomen, perineum, and perioral area.<sup><xref ref-type="bibr" rid="r04">4</xref></sup> Remission occurs until puberty in most
cases, and spontaneous remission is often observed within two years.<sup><xref ref-type="bibr" rid="r01">1</xref>,<xref ref-type="bibr" rid="r06">6</xref></sup>
The adult form can simulate lesions of bullous pemphigoid, DH, and epidermolysis bullosa
acquisita.<sup><xref ref-type="bibr" rid="r01">1</xref></sup> It most commonly
affects the limbs, trunk, buttocks, and face. In both forms, the intensity of pruritus
is variable, and there can be mucosal involvement, with the oral and ocular mucosae
being the most affected. Mucosal involvement is more common in adults. Oral lesions
consist of painful ulcers and desquamative gingivitis. Chronic conjunctivitis can lead
to synechia and even blindness. Pharyngolaryngeal involvement can lead to breathing
difficulty due to stenosis of the mucosae.<sup><xref ref-type="bibr" rid="r04">4</xref></sup>
</p>
      <p>The etiologic factor triggering the autoimmune mechanism of the disease remains unknown.
Some precipitating factors such as drugs and tumors of hematological lineage, especially
in adults, have been described.<sup><xref ref-type="bibr" rid="r01">1</xref>,<xref ref-type="bibr" rid="r04">4</xref></sup> Of the drugs implicated, the most
commonly associated with the disease is vancomycin, followed by amiodarone,
non-steroidal anti-inflammatory drugs, captopril, and ceftriaxone.<sup><xref ref-type="bibr" rid="r02">2</xref>,<xref ref-type="bibr" rid="r04">4</xref>,<xref ref-type="bibr" rid="r05">5</xref>,<xref ref-type="bibr" rid="r06">6</xref></sup>
With respect to malignancy, it has not yet been elucidated if LAD can be considered a
paraneoplastic manifestation or if it emerges concurrently with the malignancy, as mere
coincidence.<sup><xref ref-type="bibr" rid="r04">4</xref></sup>
</p>
      <p>The target antigens of IgA are located at the BMZ, more specifically at the lamina
lucida (LL) or sublamina dense (SL), or both locations. Some antigens have been
identified, including collagen VII, BP230 and BP180. Most patients develop antibodies
that react against LABD-97 (97 kd) and LAD-1 (120kd) subdomains, which are extracellular
portions of BP180, a transmembrane glycoprotein that composes the hemidesmosome of
keratinocytes of the basal layer.<sup><xref ref-type="bibr" rid="r04">4</xref>,<xref ref-type="bibr" rid="r07">7</xref></sup> Therefore, cleavage usually occurs at the
LL. </p>
      <p>An anatomopathological examination reveals subepidermal bullae with neutrophilic
infiltrate and occasional eosinophils and lymphocytes. Microabscesses in the dermal
papillae may occur.<sup><xref ref-type="bibr" rid="r03">3</xref></sup> Given these
histopathological findings, which are common to other bullous dermatoses, it is
essential to perform DIF, which shows linear and homogeneous deposition of IgA at the
BMZ. Detection of IgG and/or C3 occasionally occurs.<sup><xref ref-type="bibr" rid="r08">8</xref>,<xref ref-type="bibr" rid="r09">9</xref></sup>
</p>
      <p>Indirect immunofluorescence (IIF), which is used to detect circulating antibodies, may
be positive for IgA in 7-30% of cases and may be used to rule out other
dermatoses.<sup><xref ref-type="bibr" rid="r09">9</xref></sup> Salt-split-skin, in
general, shows fluorescence of the epidermal side of the bulla, since most antibodies
are directed against BP180 antigens, located at the LL.<sup><xref ref-type="bibr" rid="r09">9</xref></sup> However, there may be dermal-epidermal or dermal
fluorescence, depending on the target antigen. </p>
      <p>The drug of first choice for treatment of LAD is dapsone, whose main adverse effects are
methemoglobinemia and hemolytic anemia.<sup><xref ref-type="bibr" rid="r10">10</xref></sup> The risk of these complications may be minimized by measuring the
level of glucose 6-phosphate dehydrogenase, with mild anemia being present even when the
levels of this enzyme are normal. Other drugs used are sulfonamides, oral
corticosteroids, mycophenolate mofetil, azathioprine, methotrexate, and cyclosporine.
There are also reports of the use of antibiotics such as doxycycline, erythromycin, and
oxacillin.<sup><xref ref-type="bibr" rid="r04">4</xref></sup>
</p>
      <p>We reported an exuberant typical case of LAD in a ten-month old child, who responded
satisfactorily to treatment with dapsone and oral prednisolone, with dapsone being the
drug of choice for treatment of LAD. This case report shows the importance of knowing
about this disease, whose differential diagnosis includes bullous dermatoses of
childhood such as erythema multiforme, primary herpes infection, congenital
epidermolysis bullosa, and ichthyosis bullosa. We stress the importance of performing
DIF to confirm the diagnosis of the disease and to establish an appropriate
treatment.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn id="fn01" fn-type="other">
        <p>* Work conducted at Complexo Hospitalar Padre Bento de Guarulhos - Guarulhos (SP),
Brazil.</p>
      </fn>
      <fn id="fn02" fn-type="financial-disclosure">
        <p>Financial Support: none</p>
      </fn>
      <fn id="fn03" fn-type="conflict">
        <p>Conflict of Interests: none</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>REFERENCES </title>
      <ref id="r01">
        <label>1</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Rao</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Hall III</surname>
              <given-names>RP</given-names>
            </name>
          </person-group>
          <chapter-title>Dermatose por Imunoglobulina A e Doen&#xE7;a Bolhosa Cr&#xF4;nica da
inf&#xE2;ncia</chapter-title>
          <person-group person-group-type="editor">
            <name>
              <surname>Wolff</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Goldsmith</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>Katz</surname>
              <given-names>SI</given-names>
            </name>
            <name>
              <surname>Gilchrest</surname>
              <given-names>BA</given-names>
            </name>
            <name>
              <surname>Paller</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Leffell</surname>
              <given-names>DJ</given-names>
            </name>
          </person-group>
          <source>Fitzpatrick Tratado de Dermatologia</source>
          <edition>7 ed</edition>
          <publisher-loc>Rio de Janeiro</publisher-loc>
          <publisher-name>RevinterLtda</publisher-name>
          <year>2011</year>
          <fpage>485</fpage>
          <lpage>490</lpage>
        </element-citation>
      </ref>
      <ref id="r02">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Guide</surname>
              <given-names>SV</given-names>
            </name>
            <name>
              <surname>Marinkovich</surname>
              <given-names>MP</given-names>
            </name>
          </person-group>
          <article-title>Linear IgA bullous dermatosis</article-title>
          <source>Clin Dermatol</source>
          <year>2001</year>
          <volume>19</volume>
          <fpage>719</fpage>
          <lpage>727</lpage>
          <pub-id pub-id-type="pmid">11705681</pub-id>
        </element-citation>
      </ref>
      <ref id="r03">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kharfi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Khaled</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Karaa</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Zaraa</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Fazaa</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Kamoun</surname>
              <given-names>MR</given-names>
            </name>
          </person-group>
          <article-title>Linear IgA bullous dermatosis: the more frequent bullous dermatosis of
children</article-title>
          <source>Dermatol Online J</source>
          <year>2010</year>
          <volume>16</volume>
          <fpage>2</fpage>
          <lpage>2</lpage>
          <pub-id pub-id-type="pmid">20137744</pub-id>
        </element-citation>
      </ref>
      <ref id="r04">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fortuna</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Marinkovich</surname>
              <given-names>MP</given-names>
            </name>
          </person-group>
          <article-title>Linear immunoglobulin A bullous dermatosis</article-title>
          <source>Clin Dermatol</source>
          <year>2012</year>
          <volume>30</volume>
          <fpage>38</fpage>
          <lpage>50</lpage>
          <pub-id pub-id-type="pmid">22137225</pub-id>
        </element-citation>
      </ref>
      <ref id="r05">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Venning</surname>
              <given-names>VA</given-names>
            </name>
          </person-group>
          <article-title>Linear IgA disease: clinical presentation, diagnosis, and
pathogenesis</article-title>
          <source>Dermatol Clin</source>
          <year>2011</year>
          <volume>29</volume>
          <fpage>453</fpage>
          <lpage>458</lpage>
          <pub-id pub-id-type="pmid">21605811</pub-id>
        </element-citation>
      </ref>
      <ref id="r06">
        <label>6</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Sampaio</surname>
              <given-names>SAP</given-names>
            </name>
            <name>
              <surname>Rivitti</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Maruta</surname>
              <given-names>CW</given-names>
            </name>
            <name>
              <surname>Santi</surname>
              <given-names>CG</given-names>
            </name>
          </person-group>
          <chapter-title>Erup&#xE7;&#xF5;es V&#xE9;sico-Bolhosas</chapter-title>
          <person-group person-group-type="editor">
            <name>
              <surname>Sampaio</surname>
              <given-names>SAP</given-names>
            </name>
            <name>
              <surname>Rivitti</surname>
              <given-names>EA</given-names>
            </name>
          </person-group>
          <source>Dermatologia</source>
          <edition>3 ed</edition>
          <publisher-loc>S&#xE3;o Paulo</publisher-loc>
          <publisher-name>Artes M&#xE9;dicas</publisher-name>
          <fpage>326</fpage>
          <lpage>327</lpage>
          <year>2008</year>
        </element-citation>
      </ref>
      <ref id="r07">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Horv&#xE1;th</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Niedermeier</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Podstawa</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>M&#xFC;ller</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Hunzelmann</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>K&#xE1;rp&#xE1;ti</surname>
              <given-names>S</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>IgA autoantibodies in the pemphigoids and linear IgA bullous
dermatosis</article-title>
          <source>Exp Dermatol</source>
          <year>2010</year>
          <volume>19</volume>
          <fpage>648</fpage>
          <lpage>653</lpage>
          <pub-id pub-id-type="pmid">20500772</pub-id>
        </element-citation>
      </ref>
      <ref id="r08">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Morrison</surname>
              <given-names>LH</given-names>
            </name>
          </person-group>
          <article-title>Direct immunofluorescence microscopy in the diagnosis of autoimmune
bullous dermatoses</article-title>
          <source>Clin Dermatol</source>
          <year>2001</year>
          <volume>19</volume>
          <fpage>607</fpage>
          <lpage>613</lpage>
          <pub-id pub-id-type="pmid">11604308</pub-id>
        </element-citation>
      </ref>
      <ref id="r09">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Aoki</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Sousa</surname>
              <given-names>JX</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>Fukumori</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>P&#xE9;rigo</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Freitas</surname>
              <given-names>EL</given-names>
            </name>
            <name>
              <surname>Oliveira</surname>
              <given-names>ZN</given-names>
            </name>
          </person-group>
          <article-title>Direct and indirect immunofluorescence</article-title>
          <source>An Bras Dermatol</source>
          <year>2010</year>
          <volume>85</volume>
          <fpage>490</fpage>
          <lpage>500</lpage>
          <pub-id pub-id-type="pmid">20944909</pub-id>
        </element-citation>
      </ref>
      <ref id="r10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Passos</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Rabelo</surname>
              <given-names>RF</given-names>
            </name>
            <name>
              <surname>Matsuo</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Santos</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Talhari</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Talhari</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Linear IgA/IgG bullous dermatosis: successful treatment with dapsone
and mycophenolatemofetil</article-title>
          <source>AnBras Dermatol</source>
          <year>2011</year>
          <volume>86</volume>
          <fpage>747</fpage>
          <lpage>750</lpage>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
